2024 Q2 Form 10-Q Financial Statement
#000116169724000226 Filed on May 01, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| Revenue | $8.430M | $8.198M | $7.393M |
| YoY Change | 21.54% | 10.89% | 18.39% |
| Cost Of Revenue | $2.950M | $3.095M | $3.246M |
| YoY Change | -3.2% | -4.65% | 23.78% |
| Gross Profit | $5.480M | $5.103M | $4.147M |
| YoY Change | 40.94% | 23.06% | 14.49% |
| Gross Profit Margin | 65.0% | 62.25% | 56.1% |
| Selling, General & Admin | $5.320M | $5.358M | $5.426M |
| YoY Change | 0.31% | -1.26% | -1.19% |
| % of Gross Profit | 97.08% | 104.98% | 130.84% |
| Research & Development | $1.134M | $1.476M | $1.565M |
| YoY Change | -28.96% | -5.7% | 36.27% |
| % of Gross Profit | 20.7% | 28.92% | 37.73% |
| Depreciation & Amortization | $217.9K | $231.4K | $213.1K |
| YoY Change | 2.32% | 8.56% | 95.07% |
| % of Gross Profit | 3.98% | 4.53% | 5.14% |
| Operating Expenses | $6.672M | $7.065M | $7.204M |
| YoY Change | -6.2% | -1.93% | 6.74% |
| Operating Profit | -$1.192M | -$1.961M | -$3.057M |
| YoY Change | -63.03% | -35.84% | -2.23% |
| Interest Expense | $124.8K | ||
| YoY Change | -1551.4% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | $203.3K | $25.41K | $68.54K |
| YoY Change | 57.99% | -62.93% | -897.2% |
| Pretax Income | -$988.7K | -$1.936M | -$2.988M |
| YoY Change | -68.06% | -35.22% | -4.68% |
| Income Tax | -$577.4K | ||
| % Of Pretax Income | |||
| Net Earnings | -$988.7K | -$1.936M | -$2.411M |
| YoY Change | -60.39% | -19.7% | -4.99% |
| Net Earnings / Revenue | -11.73% | -23.62% | -32.61% |
| Basic Earnings Per Share | -$0.02 | -$0.04 | -$0.05 |
| Diluted Earnings Per Share | -$0.02 | -$0.04 | -$0.05 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 45.76M shares | 45.71M shares | 45.52M shares |
| Diluted Shares Outstanding | 45.81M shares | 45.71M shares | 45.49M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $12.22M | ||
| YoY Change | -45.85% | ||
| Cash & Equivalents | $10.46M | $10.82M | $12.22M |
| Short-Term Investments | |||
| Other Short-Term Assets | $1.172M | ||
| YoY Change | -22.42% | ||
| Inventory | $2.589M | $3.147M | $6.638M |
| Prepaid Expenses | $472.9K | $830.4K | $1.172M |
| Receivables | $5.846M | $4.393M | $4.165M |
| Other Receivables | $1.015M | ||
| Total Short-Term Assets | $19.37M | $19.48M | $25.21M |
| YoY Change | -14.09% | -22.75% | -25.69% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $3.679M | $3.756M | $3.906M |
| YoY Change | -3.49% | -3.85% | -35.68% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $98.97K | $98.97K | $98.97K |
| YoY Change | 0.0% | 0.0% | -96.23% |
| Total Long-Term Assets | $7.938M | $8.021M | $13.04M |
| YoY Change | -41.0% | -38.48% | 37.31% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $19.37M | $19.48M | $25.21M |
| Total Long-Term Assets | $7.938M | $8.021M | $13.04M |
| Total Assets | $27.30M | $27.50M | $38.25M |
| YoY Change | -24.15% | -28.11% | -11.91% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.596M | $1.774M | $1.503M |
| YoY Change | 1.34% | 18.03% | 18.54% |
| Accrued Expenses | $2.145M | $1.459M | $1.592M |
| YoY Change | 57.43% | -8.31% | -48.21% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $218.4K | ||
| YoY Change | -14.56% | ||
| Long-Term Debt Due | $99.69K | ||
| YoY Change | |||
| Total Short-Term Liabilities | $5.137M | $4.853M | $4.524M |
| YoY Change | 26.01% | 7.27% | -4.0% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $368.8K | ||
| YoY Change | |||
| Other Long-Term Liabilities | $3.565M | ||
| YoY Change | -8.92% | ||
| Total Long-Term Liabilities | $3.933M | ||
| YoY Change | 0.5% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $5.137M | $4.853M | $4.524M |
| Total Long-Term Liabilities | $3.933M | ||
| Total Liabilities | $8.599M | $8.383M | $8.458M |
| YoY Change | 8.92% | -0.88% | -1.96% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$26.24M | -$25.25M | -$11.98M |
| YoY Change | 81.22% | 110.72% | |
| Common Stock | $48.82M | $48.21M | $45.62M |
| YoY Change | 5.17% | 5.67% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $3.882M | $3.844M | $3.844M |
| YoY Change | 1.01% | 0.0% | |
| Treasury Stock Shares | 3.421M shares | ||
| Shareholders Equity | $18.70M | $19.12M | $29.80M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $27.30M | $27.50M | $38.25M |
| YoY Change | -24.15% | -28.11% | -11.91% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$988.7K | -$1.936M | -$2.411M |
| YoY Change | -60.39% | -19.7% | -4.99% |
| Depreciation, Depletion And Amortization | $217.9K | $231.4K | $213.1K |
| YoY Change | 2.32% | 8.56% | 95.07% |
| Cash From Operating Activities | -$346.7K | -$4.661M | |
| YoY Change | -92.56% | 166.0% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $283.8K | ||
| YoY Change | -137.71% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$133.1K | -$283.8K | |
| YoY Change | -53.11% | -62.29% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -$182.1K | -$239.0K | |
| YoY Change | -23.79% | -5.53% | |
| NET CHANGE | |||
| Cash From Operating Activities | -$346.7K | -$4.661M | |
| Cash From Investing Activities | -$133.1K | -$283.8K | |
| Cash From Financing Activities | -$182.1K | -$239.0K | |
| Net Change In Cash | -$661.9K | -$5.183M | |
| YoY Change | -87.23% | 87.96% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$346.7K | -$4.661M | |
| Capital Expenditures | $283.8K | ||
| Free Cash Flow | -$4.944M | ||
| YoY Change | 394.7% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
| CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
usd | |
| CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
| CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
| CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2024Q1 | krmd |
Anti Dilutive Stock Options
AntiDilutiveStockOptions
|
0 | shares |
| CY2024Q1 | krmd |
Common Stock Options
CommonStockOptions
|
shares | |
| CY2023Q1 | krmd |
Performance Stock Units
PerformanceStockUnits
|
shares | |
| CY2024Q1 | krmd |
Dilutive Effect Of Outstanding Stock Options And Unvested Restricted Stock
DilutiveEffectOfOutstandingStockOptionsAndUnvestedRestrictedStock
|
shares | |
| CY2023Q1 | krmd |
Dilutive Effect Of Outstanding Stock Options And Unvested Restricted Stock
DilutiveEffectOfOutstandingStockOptionsAndUnvestedRestrictedStock
|
shares | |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P6Y7M6D | |
| CY2023Q4 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P6Y10M25D | |
| CY2024Q1 | us-gaap |
Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
|
P3Y7M6D | |
| CY2023Q4 | us-gaap |
Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
|
P6Y8M12D | |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
|
usd | |
| CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | usd |
| CY2024Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
159031 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3245570 | usd |
| CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5357620 | usd |
| CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5425877 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1475674 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1564869 | usd |
| CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
231370 | usd |
| CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
213117 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
7064664 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
7203863 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1961366 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3056828 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-11479 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-680 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-300 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-56279 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
37187 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
125502 | usd |
| CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
25408 | usd |
| CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
68543 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1935958 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2988285 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-577400 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1935958 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2410885 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45712224 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45487593 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
45712224 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
45487593 | shares |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1935958 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2410885 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
699718 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
881222 | usd |
| CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
231370 | usd |
| CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
213117 | usd |
| CY2023Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-577400 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-300 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-56279 | usd |
| CY2024Q1 | krmd |
Rou Landlord Credit
RouLandlordCredit
|
-5497 | usd |
| CY2023Q1 | krmd |
Rou Landlord Credit
RouLandlordCredit
|
-5497 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
607125 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
647994 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-333989 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
233551 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-387880 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-288786 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-54867 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
4207 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
798992 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-888679 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
56500 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-41984 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-252022 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-1298204 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-346720 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4660583 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
133083 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
272605 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
11232 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-133083 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-283837 | usd |
| CY2024Q1 | krmd |
Payments On Indebtedness
PaymentsOnIndebtedness
|
155313 | usd |
| CY2023Q1 | krmd |
Payments On Indebtedness
PaymentsOnIndebtedness
|
214892 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
26807 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
24080 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-182120 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-238972 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-661923 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5183392 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11482240 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17408257 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
10820317 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
12224865 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
12296 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
12326 | usd |
| CY2024Q1 | krmd |
Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
|
123804 | usd |
| CY2023Q1 | krmd |
Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
|
175776 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20353771 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
123804 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
393113 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
130676 | usd |
| CY2024Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
52125 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1935958 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19117531 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
31325963 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
175776 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
535059 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
170387 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2410885 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
29796300 | usd |
| CY2024Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_84C_eus-gaap--NatureOfOperations_zuNRR9X8WuT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zL58AmV7DqSg">NATURE OF OPERATIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KORU MEDICAL SYSTEMS, INC. (the “Company,” “KORU Medical,” “we,” “us” or “our”) designs, manufactures and markets proprietary portable and innovative medical devices primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international regulations and standards for quality system management. The Company operates as <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxH_uN_c20240101__20240331_zHYjAdyxPnMa" title="Number of segment::XDX::1">one</span> segment.</p> | |
| CY2024Q1 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
250000 | usd |
| CY2024Q1 | us-gaap |
Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
|
10200000 | usd |
| CY2023Q1 | krmd |
Anti Dilutive Stock Options
AntiDilutiveStockOptions
|
14626 | shares |
| CY2024Q1 | krmd |
Anti Dilutive Securities
AntiDilutiveSecurities
|
904496 | shares |
| CY2023Q1 | krmd |
Anti Dilutive Securities
AntiDilutiveSecurities
|
914626 | shares |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
214910 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
197233 | usd |
| CY2023Q1 | krmd |
Common Stock Options
CommonStockOptions
|
14626 | shares |
| CY2024Q1 | krmd |
Performance Stock Units
PerformanceStockUnits
|
54496 | shares |
| CY2024Q1 | krmd |
Restricted Stock Units
RestrictedStockUnits
|
850000 | shares |
| CY2023Q1 | krmd |
Restricted Stock Units
RestrictedStockUnits
|
900000 | shares |
| CY2024Q1 | krmd |
Anti Diluted Securities
AntiDilutedSecurities
|
904496 | shares |
| CY2023Q1 | krmd |
Anti Diluted Securities
AntiDilutedSecurities
|
914626 | shares |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1935958 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2410885 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_848_eus-gaap--UseOfEstimates_zwBJwuyIaRwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zXdhu3aGikK9">USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to asset lives, deferred tax valuation allowances, inventory valuation, and customer rebate and incentive accruals. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the entire 2024 fiscal year.</p> | |
| CY2024Q1 | krmd |
Schedule Of Net Sales By Geography
ScheduleOfNetSalesByGeography
|
<p id="xdx_89B_ecustom--ScheduleOfNetSalesByGeography_zDNyTfMVxHZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BB_zofRxwMyRalc">The following table summarizes net revenues by geography for the three months ended March 31, 2024, and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Three Months Ended March 31,</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2024</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 46%"><b>Revenues</b></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right"> </td> <td style="width: 6%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td style="padding-left: 0.2in">Domestic</td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--Revenues_c20240101__20240331__srt--StatementGeographicalAxis__country--US_zfekj6YiphU1" style="text-align: right" title="Net Revenue">6,384,083</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--Revenues_c20230101__20230331__srt--StatementGeographicalAxis__country--US_zU239wHzX3td" style="text-align: right" title="Net Revenue">6,283,965</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.2in">International</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_989_eus-gaap--Revenues_c20240101__20240331__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zszLQcyBXTo6" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues">1,813,715</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_989_eus-gaap--Revenues_c20230101__20230331__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zligqYQgmNRk" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues">1,108,640</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><b>Total</b></td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98C_eus-gaap--Revenues_c20240101__20240331_zBlWjzy5lZTl" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues">8,197,798</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98F_eus-gaap--Revenues_c20230101__20230331_zgjEkojcqhJ3" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues">7,392,605</td> <td> </td></tr> </table> | |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
8197798 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
7392605 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2721273 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3755530 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3837657 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6688579 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6558930 | usd |
| CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2933049 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
512055 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
111548 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
112522 | usd |
| CY2024Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
3460 | usd |
| CY2023Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
52894 | usd |
| CY2024Q1 | us-gaap |
Lease Cost
LeaseCost
|
115008 | usd |
| CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
165416 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
28896 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
27223 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
6053 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
6720 | usd |
| CY2024Q1 | krmd |
Finance Lease Cost
FinanceLeaseCost
|
34949 | usd |
| CY2023Q1 | krmd |
Finance Lease Cost
FinanceLeaseCost
|
33943 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
120365 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
113813 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
32859 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
30800 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3428885 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3514055 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
372109 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
368313 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3241837 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3336300 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3613946 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3704613 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
577929 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
577929 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
190358 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
161461 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
387571 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
416468 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
111103 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
109540 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
288253 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
316623 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
399356 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
426163 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.0573 | pure |
| CY2023Q4 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.0576 | pure |
| CY2024Q1 | us-gaap |
Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
|
0.0617 | pure |
| CY2023Q4 | us-gaap |
Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
|
0.0619 | pure |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
384041 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
98578 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
512055 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
131437 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
131437 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
512055 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
74194 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
511009 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
6179 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
1833604 | usd |
| CY2024Q1 | krmd |
Lessee Operating Lease Liability Payments Due Total
LesseeOperatingLeaseLiabilityPaymentsDueTotal
|
4264819 | usd |
| CY2024Q1 | krmd |
Lessee Financing Lease Lease Liability Payments Due Total
LesseeFinancingLeaseLeaseLiabilityPaymentsDueTotal
|
441825 | usd |
| CY2024Q1 | krmd |
Lessee Operating Lease Imputed Interest
LesseeOperatingLeaseImputedInterest
|
650873 | usd |
| CY2024Q1 | krmd |
Lessee Financing Lease Imputed Interest
LesseeFinancingLeaseImputedInterest
|
42469 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3613946 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
399356 | usd |
| CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
600000 | usd |
| CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6000000.0 | usd |
| CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6400000 | usd |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
